Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,309,432

« Back to Dashboard

Summary for Patent: 4,309,432

Title: Compositions for treating glaucoma containing a carbostyril
Abstract:This invention provides a glaucoma treating composition comprising at least one of carbostyril derivatives represented by the formula ##STR1## wherein R.sup.1 is hydrogen, lower alkyl or lower alkenyl, R.sup.2 is hydrogen or a group ##STR2## wherein R.sup.4 is lower alkyl, cycloalkyl, or lower alkyl substituted by phenyl with or without a lower alkoxy substituent on the phenyl nucleus, R.sup.3 is a group ##STR3## wherein R.sup.4 is as defined above when R.sup.2 is hydrogen, or R.sup.3 is hydrogen, hydroxyl, ureido, lower alkynyloxy, lower alkoxy having a lower alkanoyl substitutent, lower alkanoylamino or lower alkenyloxy when R.sup.2 is ##STR4## and the carbon-to-carbon bond between the 3-position and the 4-position of the carbostyril skeleton is a single bond or double bond, and pharmacologically acceptable acid addition salts thereof; and a method of treating glaucoma comprising administering said composition to a patient with glaucoma.
Inventor(s): Tanaka; Nobuyuki (Tokushima, JP), Nishinakamura; Yoichi (Ibaragi, JP), Nakagawa; Kazuyuki (Tokushima, JP)
Assignee: Otsuka Pharmaceutical Company, Ltd. (Tokyo, JP)
Application Number:06/109,057
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,309,432

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan54/10108Jan 30, 1979
Japan54/70361Jun 06, 1979

International Patent Family for Patent: 4,309,432

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria371340<disabled in preview>
Australia518814<disabled in preview>
United Kingdom2042338<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.